FTO facilitates pancreatic cancer cells’ growth and resistance to gemcitabine by modulating phosphatase and tensin homolog (PTEN) expression and affecting the PI3K/AKT signaling cascade.180. The gene discussed is PTEN; the disease is pancreatic neoplasm.